SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC TO-T/A

Amendment to a previously filed SC TO-T

Mergers & Acquisitions
View HTML
SC TO-T/A

Amendment to a previously filed SC TO-T

Mergers & Acquisitions
View HTML
SC TO-T/A

Amendment to a previously filed SC TO-T

Mergers & Acquisitions
View HTML

Data provided by Kaleidoscope.